SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-029559
Filing Date
2020-06-16
Accepted
2020-06-16 17:19:22
Documents
12
Period of Report
2020-06-11
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K atrs-8k_20200611.htm   iXBRL 8-K 50265
  Complete submission text file 0001564590-20-029559.txt   180546

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA atrs-20200611.xsd EX-101.SCH 5796
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE atrs-20200611_lab.xml EX-101.LAB 19478
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atrs-20200611_pre.xml EX-101.PRE 11645
5 EXTRACTED XBRL INSTANCE DOCUMENT atrs-8k_20200611_htm.xml XML 3549
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32302 | Film No.: 20967316
SIC: 3841 Surgical & Medical Instruments & Apparatus
Office of Life Sciences